HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

TDP-43 pathology in polyglutamine diseases: with reference to amyotrphic lateral sclerosis.

Abstract
A nuclear protein, transactivation response (TAR) DNA binding protein 43 kDa (TDP-43), is the major component of neuronal cytoplasmic inclusions (NCIs) in frontotemporal lobar degeneration with ubiquitin inclusions (FTLD-U) and sporadic amyotrophic lateral sclerosis (SALS). While initially thought to be relatively specific to FTLD-U and ALS, TDP-43 pathology has now been detected in a number of other neurodegenerative diseases, including Alzheimer's disease and Parkinson's disease. In such tauopathies and α-synucleinopathies, occurrence of TDP-43-positive neuronal cytoplasmic inclusions may be associated with other distinct molecular pathologic processes primarily involving their own pathological proteins, tau and α-synuclein, respectively (secondary TDP-43 proteinopathies). On the other hand, in several polyglutamine (polyQ) diseases, TDP-43 appears to play an important pathomechanistic role. Interestingly, intermediate-length polyQ expansions (27-33 Qs) in ataxin 2, the causative gene of spinocerebellar ataxia type 2, have recently been reported to be a genetic risk factor for SALS. Here, with a review of the literature, we discuss the relationship between ALS and polyQ diseases from the viewpoint of TDP-43 neuropathology.
AuthorsYasuko Toyoshima, Hitoshi Takahashi
JournalNeuropathology : official journal of the Japanese Society of Neuropathology (Neuropathology) Vol. 34 Issue 1 Pg. 77-82 (Feb 2014) ISSN: 1440-1789 [Electronic] Australia
PMID23889603 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Review)
Copyright© 2013 Japanese Society of Neuropathology.
Chemical References
  • DNA-Binding Proteins
  • Peptides
  • RNA-Binding Proteins
  • polyglutamine
Topics
  • Amyotrophic Lateral Sclerosis (pathology)
  • DNA-Binding Proteins (analysis)
  • Humans
  • Huntington Disease (pathology)
  • Inclusion Bodies (pathology)
  • Machado-Joseph Disease (pathology)
  • Peptides
  • RNA-Binding Proteins (analysis)
  • Spinocerebellar Ataxias (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: